Active efflux of dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly-targeted agents

The importance of the blood-brain barrier in preventing effective pharmacotherapy of glioblastoma has been controversial. The controversy stems from the fact that vascular endothelial cell tight junctions are disrupted in the tumor, allowing some systemic drug delivery. P-glycoprotein (Pgp) and brea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Agarwal, Sagar, Mittapalli, Rajendar K., Zellmer, David M., Gallardo, Jose L., Donelson, Randy, Seiler, Charlie, Decker, Stacy A., SantaCruz, Karen S., Pokorny, Jenny L., Sarkaria, Jann N., Elmquist, William F., Ohlfest, John R.
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3469747/
https://ncbi.nlm.nih.gov/pubmed/22891038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0552
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares